Estatísticas Básicas
| CIK | 1080747 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Greenway Medical Technologies Inc
SEC Filings (Chronological Order)
Esta página fornece uma lista completa e cronológica de Arquivamentos da SEC, excluindo os arquivamentos de propriedade que fornecemos em outro lugar.
| February 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 10 3 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| November 15, 2013 |
OMB Number: 3235-0167 Expires: November 30, 2010 Estimated average burden hours per response . |
|
| November 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35413 GREENWAY MEDICAL TEC |
|
| November 5, 2013 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on November 18, 2013, pursuant to the provisions of Rule 12d2-2 (a). |
|
| November 4, 2013 |
Exhibit 99.1 Vista Equity Partners Announces Successful Completion of Cash Tender Offer for Shares of Greenway Medical Technologies, Inc. CARROLLTON, Ga. — November 4, 2013 — Greenway Medical Technologies, Inc. (NYSE: GWAY) (the “Company” or “Greenway”) and Vista Equity Partners today announced the successful completion of the tender offer by Crestview Acquisition Corp., a wholly owned subsidiary |
|
| November 4, 2013 |
GWAY / Greenway Medical Technologies Inc / Pamlico Capital II, L.P. - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Under the Securities Exchange Act of 1934 Amendment No. |
|
| November 4, 2013 |
Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Amendment No. |
|
| November 4, 2013 |
EX-99.(a)(9) Exhibit (a)(9) Vista Equity Partners Announces Successful Completion of Cash Tender Offer for Shares of Greenway Medical Technologies, Inc. CARROLLTON, Ga. — November 4, 2013 — Greenway Medical Technologies, Inc. (NYSE: GWAY) (the “Company” or “Greenway”) and Vista Equity Partners today announced the successful completion of the tender offer by Crestview Acquisition Corp., a wholly ow |
|
| November 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 6 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company (Issuer)) CRESTVIEW ACQUISITION CORP. VCG HOLDINGS, LLC (Name of Filing Persons (Offerors)) VISTA EQUITY PARTNERS FUND IV, L.P. VITERA HEALTHC |
|
| November 4, 2013 |
Exhibit 99.2 NEWS RELEASE Vitera Healthcare Solutions and Greenway Medical Technologies Combine Establishes an Innovative, Trusted Technology Partner Offering Providers Highly Interoperable Solutions to Improve Clinical and Financial Outcomes Carrollton, GA and Tampa, FL — Nov. 4, 2013 — Vitera Healthcare Solutions, LLC and Greenway Medical Technologies, Inc., leading providers of clinical, financ |
|
| November 4, 2013 |
- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on November 4, 2013 Registration No. |
|
| November 4, 2013 |
- AMENDMENT NO. 4 TO SCHEDULE 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) (Amendment No. 4) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company) GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Person Filing Statement) Common Stock, $0.0001 par value per share (Title |
|
| November 4, 2013 |
Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF GREENWAY MEDICAL TECHNOLOGIES, INC. A Delaware corporation (Adopted as of November 4, 2013) ARTICLE I OFFICES Section 1 Registered Office. The registered office of the corporation in the State of Delaware shall be located at 615 S. Dupont Highway, City of Dover, County of Kent, Delaware 19901. The name of the corporation's registered agent at such addres |
|
| November 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in charter) Delaware 001-35413 58-2412516 (State or Other jurisdiction of incorporation) (C |
|
| November 4, 2013 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION GREENWAY MEDICAL TECHNOLOGIES, INC. ARTICLE One Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GREENWAY MEDICAL TECHNOLOGIES, INC. ARTICLE One The name of the corporation is Greenway Medical Technologies, Inc. (the “Corporation”). ARTICLE Two The address of the Corporation’s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, Delaware, 19801. The name of its regist |
|
| October 28, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K/A (Amendment No. |
|
| October 25, 2013 |
Exhibit (a)(5)(B) EXECUTION COPY MEMORANDUM OF UNDERSTANDING This memorandum of understanding (“MOU”) is entered into as of October 25, 2013 and contains essential terms of a settlement agreed to in principle among plaintiff Booth Family IRA Trust, on behalf of itself and all others similarly situated as members of the putative class ( (“Plaintiff”), and defendants Greenway Medical Technologies, Inc. |
|
| October 25, 2013 |
- AMENDMENT NO. 3 TO SCHEDULE 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) (Amendment No. 3) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company) GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Person Filing Statement) Common Stock, $0.0001 par value per share (Title |
|
| October 25, 2013 |
SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 5 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company (Issuer)) CRESTVIEW ACQUISITION CORP. VCG HOLDINGS, LLC (Name of Filing Persons (Offerors)) VISTA EQUITY PARTNERS FUND IV, L.P. VITE |
|
| October 21, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| October 17, 2013 |
- AMENDMENT NO. 4 TO SCHEDULE TO-T Amendment No. 4 to Schedule TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 4 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company (Issuer)) CRESTVIEW ACQUISITION CORP. VCG HOLDINGS, LLC (Name of Filing Persons (Offerors)) VISTA EQUITY PART |
|
| October 16, 2013 |
October 16, 2013 Via E-mail Mr. Michael Fosnaugh Vista Equity Partners Fund IV, L.P. 401 Congress Avenue, Suite 3100 Austin, Texas 78701 Re: Greenway Medical Technologies, Inc. Amendment No. 3 to Schedule TO-T Filed by Crestview Acquisition Corp., VCG Holdings, LLC et al. Filed October 15, 2013 File No. 005-86773 Dear Mr. Fosnaugh: We have reviewed your amended filing and have the following commen |
|
| October 15, 2013 |
- AMENDMENT NO. 3 TO SCHEDULE TO Amendment No. 3 to Schedule TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 3 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company (Issuer)) CRESTVIEW ACQUISITION CORP. VCG HOLDINGS, LLC (Name of Filing Persons (Offerors)) VISTA EQUITY PARTNE |
|
| October 11, 2013 |
- AMENDMENT NO. 2 TO SCHEDULE 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) (Amendment No. 2) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company) GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Person Filing Statement) Common Stock, $0.0001 par value per share (Title |
|
| October 11, 2013 |
- AMENDMENT NO. 2 TO SCHEDULE TO-T Amendment No. 2 to Schedule TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 2 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company (Issuer)) CRESTVIEW ACQUISITION CORP. VCG HOLDINGS, LLC (Name of Filing Persons (Offerors)) VISTA EQUITY PART |
|
| October 11, 2013 |
EX-99.(a)(5)(B) Exhibit (a)(5)(B) IN THE SUPERIOR COURT OF GWINNETT COUNTY STATE OF GEORGIA BOOTH FAMILY TRUST IRA, On Behalf of ) Itself and All Others Similarly Situated, ) ) Civil Action No. 13A 08600-2 ) Plaintiff ) ) ) v. ) ) GREENWAY MEDICAL TECHNOLOGIES, ) VERIFIED AMENDED INC., W. THOMAS GREEN, JR., WYCHE T. ) CLASS ACTION COMPLAINT GREEN, III, ROBERT Z. HENSLEY, D. NEAL ) MORRISON, THOMAS |
|
| October 10, 2013 |
October 10, 2013 Via E-mail Mr. Michael Fosnaugh Vista Equity Partners Fund IV, L.P. 401 Congress Avenue, Suite 3100 Austin, Texas 78701 Re: Greenway Medical Technologies, Inc. Schedule TO-T filed by Crestview Acquisition Corp., VCG Holdings, LLC, Vista Equity Partners Fund IV, L.P., and Vitera Healthcare Solutions, LLC Filed on October 4, 2013 File No. 005-86773 Dear Mr. Fosnaugh: We have reviewe |
|
| October 8, 2013 |
AMENDMENT NO. 1 TO SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Amendment No. 1 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company (Issuer)) CRESTVIEW ACQUISITION CORP. VCG HOLDINGS, LLC (Name of Filing Persons (Offerors)) VISTA EQUITY PARTNERS F |
|
| October 8, 2013 |
EX-(a)(5)(A) Exhibit (a)(5)(A) IN THE SUPERIOR COURT OF GWINNETT COUNTY STATE OF GEORGIA BOOTH FAMILY TRUST IRA, On Behalf of Itself and All Others Similarly Situated, ) ) Civil Action No. |
|
| October 8, 2013 |
- AMENDMENT NO. 1 TO SCHEDULE 14D-9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) (Amendment No. 1) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company) GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Person Filing Statement) Common Stock, $0.0001 par value per share (Title |
|
| October 4, 2013 |
EX-99.(a)(1)(B) Exhibit (a)(1)(B) LETTER OF TRANSMITTAL To Tender Shares of Common Stock of GREENWAY MEDICAL TECHNOLOGIES, INC., a Delaware corporation at $20.35 NET PER SHARE Pursuant to the Offer to Purchase dated October 4, 2013 by CRESTVIEW ACQUISITION CORP., a Delaware corporation and a wholly-owned subsidiary of VCG HOLDINGS, LLC, a Delaware limited liability company THE OFFER AND WITHDRAWAL |
|
| October 4, 2013 |
EX-99.(D)(13) 21 d606474dex99d13.htm EX-99.(D)(13) Exhibit (d)(13) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger S |
|
| October 4, 2013 |
EX-99.(a)(1)(D) Exhibit (a)(1)(D) Offer To Purchase For Cash All Outstanding Shares of Common Stock of GREENWAY MEDICAL TECHNOLOGIES, INC., a Delaware corporation at $20.35 NET PER SHARE Pursuant to the Offer to Purchase dated October 4, 2013 by CRESTVIEW ACQUISITION CORP., a Delaware corporation and a direct wholly-owned subsidiary of VCG HOLDINGS, LLC, a Delaware limited liability company. THE O |
|
| October 4, 2013 |
Exhibit 99.1 Vista Equity Partners Commences Tender Offer for All Outstanding Shares of Greenway Medical Technologies, Inc. — Previously-Announced Offer Price of $20.35 Per Share in Cash — CARROLLTON, Ga. — October 4, 2013 — Greenway Medical Technologies, Inc. (NYSE: GWAY) (the “Company” or “Greenway”) and Vista Equity Partners today announced that Crestview Acquisition Corp. has commenced the pre |
|
| October 4, 2013 |
EX-99.(d)(10) Exhibit (d)(10) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth o |
|
| October 4, 2013 |
EX-99.(d)(4) Exhibit (d)(4) EXECUTION VERSION LIMITED GUARANTY THIS LIMITED GUARANTY, dated as of September 23, 2013 (this “Limited Guaranty”), is made by Vista Equity Partners Fund IV, L.P., a Delaware limited partnership (the “Guarantor”), in favor of Greenway Medical Technologies, Inc., a Delaware corporation (the “Company”). Reference is hereby made to that certain Agreement and Plan of Merger |
|
| October 4, 2013 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company) GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Person Filing Statement) Common Stock, $0.0001 par value per share (Title |
|
| October 4, 2013 |
EX-99.(d)(15) Exhibit (d)(15) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth o |
|
| October 4, 2013 |
Exhibit (d)(14) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 4, 2013 |
EX-99.(d)(12) Exhibit (d)(12) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth o |
|
| October 4, 2013 |
EX-99.(a)(1)(E) Exhibit (a)(1)(E) Offer To Purchase For Cash All Outstanding Shares of Common Stock of GREENWAY MEDICAL TECHNOLOGIES, INC., a Delaware corporation at $20.35 NET PER SHARE Pursuant to the Offer to Purchase dated October 4, 2013 by CRESTVIEW ACQUISITION CORP., a Delaware corporation and a direct wholly-owned subsidiary of VCG HOLDINGS, LLC, a Delaware limited liability company. THE O |
|
| October 4, 2013 |
EX-99.(a)(1)(A) Table of Contents Exhibit (a)(1)(A) Offer to Purchase for Cash All Outstanding Shares of Common Stock of GREENWAY MEDICAL TECHNOLOGIES, INC. at $20.35 Net Per Share by CRESTVIEW ACQUISITION CORP., a wholly–owned subsidiary of VCG HOLDINGS, LLC THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON FRIDAY, NOVEMBER 1, 2013, UNLESS THE OFFER IS EXTENDED |
|
| October 4, 2013 |
Exhibit 99.1 Vista Equity Partners Commences Tender Offer for All Outstanding Shares of Greenway Medical Technologies, Inc. — Previously-Announced Offer Price of $20.35 Per Share in Cash — CARROLLTON, Ga. — October 4, 2013 — Greenway Medical Technologies, Inc. (NYSE: GWAY) (the “Company” or “Greenway”) and Vista Equity Partners today announced that Crestview Acquisition Corp. has commenced the pre |
|
| October 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in charter) Delaware 001-35413 58-2412516 (State or Other jurisdiction of incorporation) (Co |
|
| October 4, 2013 |
SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company (Issuer)) CRESTVIEW ACQUISITION CORP. VCG HOLDINGS, LLC (Name of Filing Persons (Offerors)) VISTA EQUITY PARTNERS FUND IV, L.P. VITERA HEALTHCARE SOLU |
|
| October 4, 2013 |
EX-99.(a)(1)(G) Exhibit (a)(1)(G) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below). The Offer (as defined below) is made solely by the Offer to Purchase (as defined below), dated October 4, 2013, and the related Letter of Transmittal (as defined below) and any amendments or supplements thereto. The Offer is not being made to (nor wi |
|
| October 4, 2013 |
EX-99.(d)(16) Exhibit (d)(16) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth o |
|
| October 4, 2013 |
EX-99.(d)(18) Exhibit (d)(18) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth o |
|
| October 4, 2013 |
EX-99.(d)(8) Exhibit (d)(8) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth on |
|
| October 4, 2013 |
EX-99.(d)(5) Exhibit (d)(5) EXECUTION VERSION Vista Equity Partners Fund IV, L.P. 401 Congress Avenue Suite 3100 Austin, TX 78701 September 23, 2013 VCG Holdings, LLC c/o Vista Equity Partners Fund IV, L.P. 401 Congress Avenue Suite 3100 Austin, TX 78701 Attention: Brian N. Sheth Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger (as the same may be amended, modif |
|
| October 4, 2013 |
EX-99.(d)(2) Exhibit (d)(2) CONFIDENTIALITY AGREEMENT THIS CONFIDENTIALITY AGREEMENT (the “Agreement”) is made as of June 14, 2013 by and between Greenway Medical Technologies, Inc., a Delaware corporation (“Greenway”), and Vista Equity Partners III, LLC (“Vista”). 1. Purpose. Greenway and Vista wish to explore a potential negotiated transaction under which each may disclose its or its Affiliates’ |
|
| October 4, 2013 |
JEFFERIES FINANCE LLC 520 Madison Avenue New York, NY 10022 EX-99.(b)(1) Exhibit (b)(1) Execution Version JEFFERIES FINANCE LLC 520 Madison Avenue New York, NY 10022 BANK OF MONTREAL BMO CAPITAL MARKETS CORP. 3 Times Square 28th Floor New York, NY 10036 September 20, 2013 Vitera Healthcare Solutions, LLC 4301 W Boy Scout Blvd, Suite 800 Tampa, FL 33607 VCG Holdings, LLC Attn: Vista Equity Partners 2 Prudential Plaza 180 N. Stetson Avenue, Suite 4000 Chicag |
|
| October 4, 2013 |
EX-99.(d)(11) Exhibit (d)(11) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth o |
|
| October 4, 2013 |
EX-99.(d)(6) Exhibit (d)(6) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth on |
|
| October 4, 2013 |
FIRST AMENDMENT TO CONFIDENTIALITY AGREEMENT EX-99.(d)(3) Exhibit (d)(3) FIRST AMENDMENT TO CONFIDENTIALITY AGREEMENT THIS FIRST AMENDMENT TO CONFIDENTIALITY AGREEMENT (the “Amendment”) is made as of September 6, 2013 by and between Greenway Medical Technologies, Inc., a Delaware corporation (“Greenway”), and Vista Equity Partners III, LLC (“Vista”). All initially capitalized terms used but not defined herein shall have the meanings set fort |
|
| October 4, 2013 |
Exhibit (d)(17) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 4, 2013 |
Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in charter) Delaware 001-35413 58-2412516 (State or Other jurisdiction of incorporation) (Co |
|
| October 4, 2013 |
EX-99.(d)(7) Exhibit (d)(7) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth on |
|
| October 4, 2013 |
EX-99.(d)(9) Exhibit (d)(9) EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder set forth on |
|
| October 4, 2013 |
EX-99.(a)(8) Exhibit (a)(8) Vista Equity Partners Commences Tender Offer for All Outstanding Shares of Greenway Medical Technologies, Inc. — Previously-Announced Offer Price of $20.35 Per Share in Cash — CARROLLTON, Ga. — October 4, 2013 — Greenway Medical Technologies, Inc. (NYSE: GWAY) (the “Company” or “Greenway”) and Vista Equity Partners today announced that Crestview Acquisition Corp. has co |
|
| October 4, 2013 |
EX-99.(a)(1)(C) Exhibit (a)(1)(C) NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Common Stock of GREENWAY MEDICAL TECHNOLOGIES, INC., a Delaware corporation at $20.35 NET PER SHARE Pursuant to the Offer to Purchase dated October 4, 2013 by CRESTVIEW ACQUISITION CORP., a Delaware corporation and a direct wholly-owned subsidiary of VCG HOLDINGS, LLC, a Delaware limited liability company THE O |
|
| October 3, 2013 |
EX-16 Exhibit 16 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-3 Exhibit 3 EXECUTION VERSION Vista Equity Partners Fund IV, L.P. 401 Congress Avenue Suite 3100 Austin, TX 78701 September 23, 2013 VCG Holdings, LLC c/o Vista Equity Partners Fund IV, L.P. 401 Congress Avenue Suite 3100 Austin, TX 78701 Attention: Brian N. Sheth Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger (as the same may be amended, modified or restat |
|
| October 3, 2013 |
EX-9 Exhibit 9 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
GWAY / Greenway Medical Technologies Inc / Crestview Acquisition Corp. - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 39679B103 (CUSIP Number) David Breach, Esq. Daniel Wolf, Esq. Kirkland & Ellis LLP 601 Lexington Avenue New York, NY 10022 (212) 446-4800 ( |
|
| October 3, 2013 |
EX-6 Exhibit 6 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-13 Exhibit 13 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-11 Exhibit 11 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-15 Exhibit 15 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-12 Exhibit 12 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
JEFFERIES FINANCE LLC 520 Madison Avenue New York, NY 10022 EX-2 Exhibit 2 Execution Version JEFFERIES FINANCE LLC 520 Madison Avenue New York, NY 10022 BANK OF MONTREAL BMO CAPITAL MARKETS CORP. |
|
| October 3, 2013 |
EX-14 Exhibit 14 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-4 Exhibit 4 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-10 Exhibit 10 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-99.2 Exhibit 99.2 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each of VEPF IV AIV I, L.P., Vista Equity Partners Fund IV GP, LLC, VEFIIGP, LLC and Robert F. Smith (each, a “Grantor”) has made, constituted and appointed, and by these presents does make, constitute and appoint, John Warnken-Brill (“Attorney”), the true and lawful agent and attorney-in-fact, with full power of subst |
|
| October 3, 2013 |
EX-7 Exhibit 7 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp. |
|
| October 3, 2013 |
EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of Greenway Med |
|
| September 27, 2013 |
EX-1 2 a13-214011ex1.htm EX-1 Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Amendment No. 1 to the Statement on Schedule 13D to which this exhibit is attached is filed on behalf of each of them in the capacities set forth below. Dated: September 27, 2013 Pamlico Capital II, L.P. By: Pa |
|
| September 27, 2013 |
EX-3 3 a13-214011ex3.htm EX-3 Exhibit 3 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of September 23, 2013, is by and among VCG Holdings, LLC, a Delaware limited liability company (“Parent”), Crestview Acquisition Corp., a Delaware corporation and a wholly-owned direct or indirect subsidiary of Parent (“Merger Sub”), and the stockholder s |
|
| September 27, 2013 |
GWAY / Greenway Medical Technologies Inc / Pamlico Capital II, L.P. - SC 13D/A Activist Investment SC 13D/A 1 a13-214011sc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Under the Securities Exchange Act of 1934 Amendment No. 1 Greenway Medical Technologies, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 103 (CUSIP Number) Pamlico Capital II, L.P. c/o Pamlico Capital 150 North College St |
|
| September 23, 2013 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among: Greenway Medical Technologies, Inc., a Delaware corporation; VCG Holdings, LLC, a Delaware limited liability company; and Crestview Acquisition Corp., a Delaware corporation Dated as of September 23, 2013 The Merger Agreement has been provided solely to inform investors of its terms. The Merger Agreement contains customary represent |
|
| September 23, 2013 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among: Greenway Medical Technologies, Inc., a Delaware corporation; VCG Holdings, LLC, a Delaware limited liability company; and Crestview Acquisition Corp., a Delaware corporation Dated as of September 23, 2013 The Merger Agreement has been provided solely to inform investors of its terms. The Merger Agreement contains customary represent |
|
| September 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in charter) Delaware 001-35413 58-2412516 (State or Other jurisdiction of incorporation) |
|
| September 23, 2013 |
Exhibit 99.1 NEWS RELEASE Greenway Medical Technologies and Vitera Healthcare Solutions to Combine Vista Equity Partners, owner of Vitera, to acquire all outstanding Greenway common stock for $20.35 per share in a transaction valued at approximately $644 million Carrollton, GA, and Tampa, FL, September 23, 2013 — Greenway Medical Technologies, Inc. (NYSE: GWAY) today announced a definitive agreeme |
|
| September 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in charter) Delaware 001-35413 58-2412516 (State or Other jurisdiction of incorporation) |
|
| September 23, 2013 |
SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Subject Company (Issuer)) CRESTVIEW ACQUISITION CORP. VCG HOLDINGS, LLC (Name of Filing Persons (Offerors)) VISTA EQUITY PARTNERS FUND IV, L.P. (Names |
|
| September 23, 2013 |
Exhibit 99.1 NEWS RELEASE Greenway Medical Technologies and Vitera Healthcare Solutions to Combine Vista Equity Partners, owner of Vitera, to acquire all outstanding Greenway common stock for $20.35 per share in a transaction valued at approximately $644 million Carrollton, GA, and Tampa, FL, September 23, 2013 — Greenway Medical Technologies, Inc. (NYSE: GWAY) today announced a definitive agreeme |
|
| September 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 GREENWAY MEDICAL TECHOLOGIES, INC. (Name of Subject Company) GREENWAY MEDICAL TECHOLOGIES, INC. (Name of Person Filing Statement) Common Stock, $0.0001 par value per share (Title of Class of Securit |
|
| September 13, 2013 |
10-K 1 t7736910k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-35413 Greenway Medical Techno |
|
| September 13, 2013 |
Exhibit 21 Greenway Medical Technologies, Inc. The following table lists the direct and indirect subsidiaries of Greenway Medical Technologies, Inc. Name Jurisdiction of Incorporation or Organization Greenway, LLC Delaware Greenway Registry, LLC Georgia |
|
| September 13, 2013 |
FOURTH AMENDMENT TO CREDIT AGREEMENT Exhibit 10.6.4 FOURTH AMENDMENT TO CREDIT AGREEMENT THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of June 10, 2013, by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation, as the borrower (the “Borrower”), each of the lenders party hereto (collectively, the “Lenders”), and BANK OF AMERICA, N.A., a national banking association, as the ad |
|
| September 13, 2013 |
THIRD AMENDMENT TO CREDIT AGREEMENT Exhibit 10.6.3 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of March 14, 2013, by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation, as the borrower (the “Borrower”), each of the lenders party hereto (collectively, the “Lenders”), and BANK OF AMERICA, N.A., a national banking association, as the adm |
|
| August 19, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisdiction of inco |
|
| August 19, 2013 |
Greenway Reports Fourth-Quarter and Fiscal 2013 Results Exhibit 99.1 Greenway Reports Fourth-Quarter and Fiscal 2013 Results CARROLLTON, Ga.-(BUSINESS WIRE)-August 19, 2013-Greenway Medical Technologies, Inc. (NYSE: GWAY), reported results from operations for the three months and year ended June 30, 2013, that reflect the ongoing shift in revenue from recurring sources as more providers adopt the Company’s cloud-based subscription services and clinical |
|
| May 24, 2013 |
May 24, 2013 Via E-mail James A. Cochran Chief Financial Officer Greenway Medical Technologies, Inc. 121 Greenway Boulevard Carrollton, Georgia 30117 Re: Greenway Medical Technologies, Inc. Form 10-K for the Fiscal Year Ended June 30, 2012 Filed September 21, 2012 File No. 001-35413 Dear Mr. Cochran: We have completed our review of your filing. We remind you that our comments or changes to disclos |
|
| May 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35413 GREENWAY MEDICAL TECHNOL |
|
| May 6, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisdiction of incorpor |
|
| May 6, 2013 |
Greenway Reports Fiscal 2013 Third-Quarter Results Exhibit 99.1 Greenway Reports Fiscal 2013 Third-Quarter Results CARROLLTON, Ga.-(BUSINESS WIRE)-May 6, 2013-Greenway Medical Technologies, Inc. (NYSE: GWAY), which delivers innovative software and business service solutions for healthcare care providers through its PrimeSUITE® platform, today announced financial results for the three months and nine months ended March 31, 2013. “Our efforts to shi |
|
| April 30, 2013 |
EXHIBIT 99.1 NEWS RELEASE CORRECTING and REPLACING Greenway Revises Fiscal 2013 Outlook Expects Revenue of $132-$134 Million, Adjusted EBITDA of $5.8-$6.8 Million CORRECTION...by Greenway Technologies CARROLLTON, Ga.-(BUSINESS WIRE)-In the revised outlook for fiscal 2013 table, GAAP net income (loss) should be ($3.7) to ($3.2) [sted ($6.7) to ($5.7)]. The corrected release reads: Greenway Revises |
|
| April 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other juris |
|
| April 29, 2013 |
VIA EDGAR April 29, 2013 U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Kathleen Collins, Accounting Branch Chief Re: Greenway Medical Technologies, Inc. Form 10-K for the Fiscal Year Ended June 30, 2012 Filed September 21, 2012 File No. 001-35413 Dear Ms. Collins: Set forth below are responses from Greenway Medical Technolo |
|
| April 29, 2013 |
EXHIBIT 99.1 NEWS RELEASE Greenway Revises Fiscal 2013 Outlook Expects Revenue of $132-$134 million, Adjusted EBITDA of $5.8-$6.8 million April 29, 2013, Carrollton, GA — Based on its preliminary results for the third quarter of fiscal 2013 as well as its estimates for the fiscal fourth quarter, Greenway Medical Technologies, Inc. (NYSE: GWAY), is revising its previously issued outlook for its 201 |
|
| April 29, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisdi |
|
| April 16, 2013 |
April 16, 2013 Via E-mail James A. Cochran Chief Financial Officer Greenway Medical Technologies, Inc. 121 Greenway Boulevard Carrollton, Georgia 30117 Re: Greenway Medical Technologies, Inc. Form 10-K for the Fiscal Year Ended June 30, 2012 Filed September 21, 2012 File No. 001-35413 Dear Mr. Cochran: We have reviewed your letter dated March 29, 2013 in connection with the above- referenced filin |
|
| March 29, 2013 |
March 29, 2013 U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Kathleen Collins, Accounting Branch Chief Re: Greenway Medical Technologies, Inc. Form 10-K for the Fiscal Year Ended June 30, 2012 Filed September 21, 2012 File No. 001-35413 Dear Ms. Collins: Set forth below are responses from Greenway Medical Technologies, Inc. |
|
| March 15, 2013 |
March 15, 2013 Via E-mail James A. Cochran Chief Financial Officer Greenway Medical Technologies, Inc. 121 Greenway Boulevard Carrollton, Georgia 30117 Re: Greenway Medical Technologies, Inc. Form 10-K for the Fiscal Year Ended June 30, 2012 Filed September 21, 2012 File No. 001-35413 Dear Mr. Cochran: We have reviewed your filing and have the following comments. In some of our comments, we may as |
|
| February 14, 2013 |
Exhibit 2 Joint Filing Agreement THIS JOINT FILING AGREEMENT (this “Agreement”) is entered into as of the 14th day of February, 2013, by and among W. |
|
| February 14, 2013 |
Exhibit 2 Joint Filing Agreement THIS JOINT FILING AGREEMENT (this “Agreement”) is entered into as of the 14th day of February, 2013, by and among W. |
|
| February 14, 2013 |
GWAY / Greenway Medical Technologies Inc / GREEN W T JR - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* Greenway Medical Technologies, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B103 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| February 14, 2013 |
Members of the Group Pursuant to Item 8. Exhibit 1 Members of the Group Pursuant to Item 8. Pursuant to Item 8 of this Schedule 13G, the members of the group with respect to the common stock owned of record by Partnership are Mr. Green, Mrs. Green, and Partnership, and the members of the group with the respect to the common stock owned of record by Mrs. Green are Mr. Green and Mrs. Green. Partnership is the record owner of 971,273 shares |
|
| February 14, 2013 |
Members of the Group Pursuant to Item 8. Exhibit 1 Members of the Group Pursuant to Item 8. Pursuant to Item 8 of this Schedule 13G, the members of the group with respect to the common stock owned of record by Partnership are Mr. Green, Mrs. Green, and Partnership, and the members of the group with the respect to the common stock owned of record by Mrs. Green are Mr. Green and Mrs. Green. Partnership is the record owner of 971,273 shares |
|
| February 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35413 GREENWAY MEDICAL TECH |
|
| February 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* Greenway Medical Technologies, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B103 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| February 13, 2013 |
GWAY / Greenway Medical Technologies Inc / INVESTOR AB - GREENWAY SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 10 3 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 12, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2013 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisdiction of in |
|
| February 12, 2013 |
Exhibit 99.1 Greenway Reports Fiscal 2013 Second-Quarter Results, Revises Outlook for Fiscal 2013 12% Q2 Revenue Growth Driven by Higher Recurring Revenue Mix 32% Growth of Revenue from Recurring Sources Gross Margin of 53% for Second Quarter Improves by 177 Basis Points YOY CARROLLTON, Ga.-(BUSINESS WIRE)-February 12, 2013-Greenway Medical Technologies, Inc. (NYSE: GWAY), which delivers innovativ |
|
| January 2, 2013 |
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.+P94P`C$+`P<#7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@ M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)= M+TUE9&EA0F]X6S`@," |
|
| November 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35413 GREENWAY MEDICAL TEC |
|
| November 9, 2012 |
Submission of Matters to a Vote of Security Holders - FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2012 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisdiction of inc |
|
| November 1, 2012 |
Exhibit 99.1 Greenway Reports Fiscal 2013 First-Quarter Results First-Quarter Revenue of $32.8 Million Grew By 28% YOY Gross Margin of 54% for Quarter Improves by 262 Basis Points YOY Adjusted EBITDA Up 181% YOY to $2.6 Million CARROLLTON, Ga.-(BUSINESS WIRE)-November 1, 2012-Greenway Medical Technologies, Inc. (NYSE: GWAY), which delivers innovative software and business services solutions for am |
|
| November 1, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2012 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisdiction of inc |
|
| September 28, 2012 |
Exhibit 10.1 CONFIDENTIAL CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. Compensation Plan 2013 Name: Base Compensation: $ per pay period The 2013 incentive Bonus Plan includes three primary components: a. One component based on Company Sales Bookings b. One component based on Company Revenue c. One co |
|
| September 28, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2012 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jur |
|
| September 25, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| September 25, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Defin |
|
| September 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-35413 Greenway Medical Technologies, Inc. |
|
| August 29, 2012 |
Exhibit 99.1 NEWS RELEASE For more information, contact: Al Cochran, Chief Financial Officer, (678) 839-5860, [email protected] Bob Kneeley, Vice President, Investor Relations, (678) 390-7262, [email protected] GREENWAY REPORTS RECORD FOURTH QUARTER AND FISCAL 2012 RESULTS Fourth Quarter Revenue of $36.4 Million Increased 24% YOY Gross Margin of 60% for Quarter Adjusted EB |
|
| August 29, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2012 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisd |
|
| May 10, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35413 GREENWAY MEDICAL TECHNOL |
|
| May 10, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2012 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisdict |
|
| May 10, 2012 |
Exhibit 99.1 NEWS RELEASE For more information, contact: Al Cochran, Chief Financial Officer, (678) 839-5860,[email protected] Bob Kneeley, Vice President, Investor Relations, (678) 390-7262, [email protected] GREENWAY REPORTS THIRD-QUARTER 2012 RESULTS Record Revenue of $32.9 Million Increased 52% YOY Gross Margin of 55% for Quarter Operating Income Margin of 7% for Quart |
|
| April 5, 2012 |
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,B]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.,P94P`C$+`P<#@B?D1<@P`#"(P6W#0IE;F1S=')E M86T-96YD;V)J#3$Q(#`@;V)J#3P\+TUE=&%D871A(#(@,"!2+U!A9V5,86)E M;',@-B`P(%(O4&%G97,@." |
|
| March 30, 2012 |
Exhibit 3 LOCK-UP AGREEMENT J. P. MORGAN SECURITIES LLC 383 MADISON AVENUE NEW YORK, NY 10179 MORGAN STANLEY & CO. LLC 1585 BROADWAY NEW YORK, NY 10036 As Representatives of the several Underwriters listed in Schedule 1 to the Underwriting Agreement referred to below Re: Greenway Medical Technologies, Inc. - Public Offering Ladies and Gentlemen: The undersigned understands that you, as Representat |
|
| March 30, 2012 |
Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13D to which this exhibit is attached is filed on behalf of each of them in the capacities set forth below. |
|
| March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE ? 240. |
|
| March 15, 2012 |
As filed with the Securities and Exchange Commission on March 15, 2012 Registration No. |
|
| March 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35413 GREENWAY MEDICAL TECH |
|
| March 13, 2012 |
GREENWAY REPORTS SECOND-QUARTER 2012 RESULTS Revenue of $29.1 Million Increased 30% YOY EXHIBIT 99.1 NEWS RELEASE For more information, contact: Al Cochran, Chief Financial Officer, (678) 839-5860, [email protected] GREENWAY REPORTS SECOND-QUARTER 2012 RESULTS Revenue of $29.1 Million Increased 30% YOY March 13, 2012, Carrollton, Ga. – Greenway Medical Technologies, Inc. (NYSE: GWAY), provider of the integrated electronic health record (EHR), practice management and inter |
|
| March 13, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2012 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other jurisdi |
|
| March 5, 2012 |
Exhibit 10.1 CONFIDENTIAL CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. Compensation Plan 2012 Name: Base Compensation: $ per pay period The 2012 incentive Bonus Plan includes three primary components: a. One component based on Company Sales Bookings b. One component based on Company Revenue c. One co |
|
| March 5, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2012 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-35413 Delaware 58-2412516 (State or other juri |
|
| March 5, 2012 |
GREENWAY MEDICAL TECHNOLOGIES, INC. 2011 STOCK PLAN Stock Option Award Agreement Exhibit 10.2 GREENWAY MEDICAL TECHNOLOGIES, INC. 2011 STOCK PLAN Stock Option Award Agreement You are hereby awarded this stock option (the “Option”) to purchase Shares of Greenway Medical Technologies, Inc. (the “Company”), subject to the terms and conditions set forth in this Stock Option Award Agreement (the “Award Agreement”) and in Greenway Medical Technologies, Inc. 2011 Stock Plan (the “Pla |
|
| February 2, 2012 |
Greenway Medical Technologies, Inc. 6,666,667 Shares Filed Pursuant to Rule 433 Registration No. 333-175619 Greenway Medical Technologies, Inc. 6,666,667 Shares February 1, 2012 On January 27, 2012, Greenway Medical Technologies (“Greenway”) filed Amendment No. 5 to its Registration Statement on Form S-1 (Commission File No. 333-175619) (the “Registration Statement”) to revise certain disclosures in the preliminary prospectus (the “Previous Prelimin |
|
| February 2, 2012 |
Dated February 1, 2012 6,666,667 Shares Greenway Medical Technologies, Inc. Common Stock Table of Contents Filed Pursuant to Rule 424(b)(4) Registration Number 333-175619 Dated February 1, 2012 6,666,667 Shares Greenway Medical Technologies, Inc. |
|
| February 2, 2012 |
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C,Y(#`@;V)J#3P\+TQI;F5AF4@-3(O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1())-CC@,2G[PQ,C`S;0+(,C.C$?\:Y?P`"#`#4=P?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU,2`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>C0RH@)$! M),O1@"S&`L4,##<8N!FXV)U9%D"5RM5#:"9?9,5&RA!11E.```,`!/(%#0T* M96YD7!E+U!A9V4^/@UE;F1O8FH |
|
| January 31, 2012 |
January 31, 2012 VIA Edgar United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| January 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Greenway Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 58-2412516 (State of incorporation or organization) (I.R.S. Employer Identification No.) 121 Gr |
|
| January 30, 2012 |
January 30, 2012 Mr. Justin Dobbie United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 3561 Washington, D.C. 20549 Re: Greenway Medical Technologies, Inc. (the “Registrant”) Registration Statement on Form S-1 Registration File No. 333-175619 Ladies and Gentlemen: In connection with the above-captioned Registration Statement, we wish to advi |
|
| January 30, 2012 |
January 30, 2012 VIA Edgar United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| January 27, 2012 |
Converted by EDGARwiz 1(404) 815-2227 [email protected] January 27, 2012 76551.00006 VIA EDGAR AND OVERNIGHT DELIVERY U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Re: Greenway Medical Technologies, Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed January 17, 2011 |
|
| January 27, 2012 |
Table of Contents As filed with the Securities and Exchange Commission on January 27, 2012 Registration Statement No. |
|
| January 27, 2012 |
January 26, 2012 Via E-mail Wyche T. Green, III President, Chief Executive Officer Greenway Medical Technologies, Inc. 121 Greenway Boulevard Carrollton, GA 30117 Re: Greenway Medical Technologies, Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed January 18, 2012 File No. 333-175619 Dear Mr. Green: We have reviewed your response to our letter dated December 15, 2011 and have the fo |
|
| January 18, 2012 |
GREENWAY MEDICAL TECHNOLOGIES, INC. 2011 STOCK PLAN Exhibit 10.1 GREENWAY MEDICAL TECHNOLOGIES, INC. 2011 STOCK PLAN 1. Introduction. (a) Purpose. By resolution of its Board of Directors approved on November 16, 2011, Greenway Medical Technologies, Inc. (the “Company”) hereby establishes this equity-based incentive compensation plan to be known as the “Greenway Medical Techologies, Inc. 2011 Stock Plan” (the “Plan”), for the following purposes: (i) |
|
| January 18, 2012 |
GREENWAY MEDICAL TECHNOLOGIES, INC. FORM OF INDEMNIFICATION AGREEMENT Exhibit 10.4 GREENWAY MEDICAL TECHNOLOGIES, INC. FORM OF INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is effective as of , 2012 by and between Greenway Medical Technologies, Inc., a Delaware corporation (the “Company”), and (the “Indemnitee”). RECITALS WHEREAS, the Company recognizes the continued difficulty in obtaining liability insurance for its directors, officer |
|
| January 18, 2012 |
GREENWAY MEDICAL TECHNOLOGIES, INC. 2004 STOCK PLAN EX-10.2.2 8 d29016ex10-22.htm EX-10.2.2 Exhibit 10.2.2 GREENWAY MEDICAL TECHNOLOGIES, INC. 2004 STOCK PLAN WHEREAS, Greenway Medical Technologies, Inc. (the “Company”) maintains the Greenway Medical Technologies, Inc. 2004 Stock Plan (the “Plan”), and Section 11(b) of the Plan permits the Company’s Board of Directors (the “Board”) to amend the Plan at any time; and WHEREAS, the Board desires to am |
|
| January 18, 2012 |
Converted by EDGARwiz Exhibit 1.1 GREENWAY MEDICAL TECHNOLOGIES, INC. Shares of Common Stock (Par Value $0.0001 Per Share) Form of Underwriting Agreement , 2012 UNDERWRITING AGREEMENT , 2012 J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 As Representatives of the several Underwriters listed in Schedule 1 hereto |
|
| January 18, 2012 |
SECOND AMENDMENT TO AND CONSENT UNDER CREDIT AGREEMENT Converted by EDGARwiz Exhibit 10.6.2 EXECUTION VERSION SECOND AMENDMENT TO AND CONSENT UNDER CREDIT AGREEMENT THIS SECOND AMENDMENT TO AND CONSENT UNDER CREDIT AGREEMENT (this “Amendment”) is made and entered into as of December 1, 2011, by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation, as the borrower (the “Borrower”), each of the lenders party hereto (collectively, the “ |
|
| January 18, 2012 |
Converted by EDGARwiz 1(404) 815-2227 [email protected] January 17, 2012 76551.00006 VIA EDGAR AND OVERNIGHT DELIVERY U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Re: Greenway Medical Technologies, Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed January 17, 2012 |
|
| January 18, 2012 |
Converted by EDGARwiz Exhibit 10.9 Compensation Plan 2011 Name: Base Compensation: $ per pay period The 2011 incentive Bonus Plan includes three primary components: a. One component based on Company Sales Bookings b. One component based on Company Revenue c. One component based on Company EBITDA d. The “Targets” for the Bonus Plan exceed the 2011 Budget EBITDA Target Bonus 30% Sales Bookings Targe |
|
| January 18, 2012 |
Exhibit 14 GREENWAY MEDICAL TECHNOLOGIES, INC. CODE OF BUSINESS CONDUCT AND ETHICS FOR EMPLOYEES, OFFICERS AND DIRECTORS Introduction Greenway Medical Technologies, Inc. (“Greenway”) is committed to maintaining the highest standards of business conduct and ethics. This Code of Business Conduct and Ethics (the “Code”) reflects the business practices and principles of behavior that support this comm |
|
| January 18, 2012 |
CERTIFICATE OF INCORPORATION GREENWAY MEDICAL TECHNOLOGIES, INC. Exhibit 3.2 CERTIFICATE OF INCORPORATION OF GREENWAY MEDICAL TECHNOLOGIES, INC. FIRST: The name of the corporation is Greenway Medical Technologies, Inc. (hereinafter referred to as the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is the Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, in the County of New Castle |
|
| January 18, 2012 |
GREENWAY MEDICAL TECHNOLOGIES, INC. BYLAWS ARTICLE I - STOCKHOLDERS Converted by EDGARwiz Exhibit 3.3 GREENWAY MEDICAL TECHNOLOGIES, INC. BYLAWS ARTICLE I - STOCKHOLDERS Section 1. Annual Meeting. An annual meeting of the stockholders of Greenway Medical Technologies, Inc. (the “Corporation”), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting in accordance with S |
|
| January 18, 2012 |
Table of Contents As filed with the Securities and Exchange Commission on January 17, 2012 Registration Statement No. |
|
| January 18, 2012 |
Greenway Medical Technologies, Inc. Converted by EDGARwiz Exhibit 21 Greenway Medical Technologies, Inc. The following table lists the direct and indirect subsidiaries of Greenway Medical Technologies, Inc. Name Jurisdiction of Incorporation Greenway Medical Technologies, Inc.* DE * Immediately prior to the closing of this offering, Greenway Medical Technologies, Inc., the Georgia corporation, will merge with and into its wholly-own |
|
| January 18, 2012 |
THIS CERTIFIES THAT is the owner of CUSIP DATED COUNTERSIGNED AND REGISTERED: COMPUTERSHARE TRUST COMPANY, N. |
|
| January 6, 2012 |
1(404) 815-2227 [email protected] January 6, 2012 76551.00006 VIA EDGAR AND OVERNIGHT DELIVERY U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Re: Greenway Medical Technologies, Inc. Amendment No. 3 to Registration Statement on Form S-1 Filed December 5, 2011 File No. 333-175619 Dea |
|
| December 16, 2011 |
December 15, 2011 Via E-mail Wyche T. Green, III President, Chief Executive Officer Greenway Medical Technologies, Inc. 121 Greenway Boulevard Carrollton, GA 30117 Re: Greenway Medical Technologies, Inc. Amendment No. 3 to Registration Statement on Form S-1 Filed December 5, 2011 File No. 333-175619 Dear Mr. Green: We have reviewed your response to our letter dated October 5, 2011 and have the fol |
|
| December 5, 2011 |
Converted by EDGARwiz CONFIDENTIAL Exhibit 10.8 CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. SOFTWARE LICENSE AND SERVICES AGREEMENT This Software License and Services Agreement (the “Agreement”) is made and entered into as of the date of the last signature below (“Effective Date”) by and between GRE |
|
| December 5, 2011 |
FIRST AMENDMENT TO, LIMITED WAIVER AND CONSENT UNDER CREDIT AGREEMENT Converted by EDGARwiz Exhibit 10.6.1 FIRST AMENDMENT TO, LIMITED WAIVER AND CONSENT UNDER CREDIT AGREEMENT THIS FIRST AMENDMENT TO, LIMITED WAIVER AND CONSENT UNDER CREDIT AGREEMENT (this “Amendment”) is made and entered into as of September 23, 2011, by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation, as the borrower (the “Borrower”), each of the lenders party hereto (colle |
|
| December 5, 2011 |
Table of Contents As filed with the Securities and Exchange Commission on December 5 , 2011 Registration Statement No. |
|
| December 5, 2011 |
Exhibit 10.9 CONFIDENTIAL CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. Compensation Plan 2011 Name: Base Compensation: $ per pay period The 2011 incentive Bonus Plan includes three primary components: a. One component based on Company Sales Bookings b. One component based on Company Revenue c. One co |
|
| December 5, 2011 |
1(404) 815-2227 [email protected] December 5, 2011 76551.00006 VIA EDGAR AND OVERNIGHT DELIVERY U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Re: Greenway Medical Technologies, Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed September 23, 2011 File No. 333-175619 |
|
| October 5, 2011 |
October 5, 2011 Via E-mail Wyche T. Green, III President, Chief Executive Officer Greenway Medical Technologies, Inc. 121 Greenway Boulevard Carrollton, GA 30117 Re: Greenway Medical Technologies, Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed September 23, 2011 File No. 333-175619 Dear Mr. Green: We have reviewed your response to our letter dated September 14, 2011 and have the |
|
| September 23, 2011 |
Converted by EDGARwiz 1(404) 815-2227 [email protected] September 23, 2011 76551.00006 VIA EDGAR AND OVERNIGHT DELIVERY U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Re: Greenway Medical Technologies, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed August 26, 2011 |
|
| September 23, 2011 |
Table of Contents As filed with the Securities and Exchange Commission on September 23 , 2011 Registration Statement No. |
|
| September 23, 2011 |
CONFIDENTIAL Exhibit 10.8 CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. SOFTWARE LICENSE AND SERVICES AGREEMENT This Software License and Services Agreement (the “Agreement”) is made and entered into as of the date of the last signature below (“Effective Date”) by and between GREENWAY MEDICAL TECHNOLO |
|
| September 23, 2011 |
Exhibit 4.2 |
|
| September 23, 2011 |
Exhibit 4.3 |
|
| September 23, 2011 |
AMENDED AND RESTATED ARTICLES OF INCORPORATION OF GREENWAY MEDICAL TECHNOLOGIES, INC. Exhibit 3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF GREENWAY MEDICAL TECHNOLOGIES, INC. Greenway Medical Technologies, Inc., a corporation organized and existing under and by virtue of the provisions of the Georgia Business Corporation Code does hereby certify: FIRST: That the name of the corporation is Greenway Medical Technologies, Inc. (the “Corporation”). SECOND: That the Board of Di |
|
| September 23, 2011 |
Exhibit 10.9 CONFIDENTIAL CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. Compensation Plan 2011 Name: Base Compensation: $ per pay period The 2011 incentive Bonus Plan includes three primary components: a. One component based on Company Sales Bookings b. One component based on Company Revenue c. One co |
|
| September 14, 2011 |
September 14, 2011 Via E-mail Wyche T. Green, III President, Chief Executive Officer Greenway Medical Technologies, Inc. 121 Greenway Boulevard Carrollton, GA 30117 Re: Greenway Medical Technologies, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed August 26, 2011 File No. 333-175619 Dear Mr. Green: We have reviewed your response to our letter dated August 11, 2011 and have the fol |
|
| August 26, 2011 |
Table of Contents As filed with the Securities and Exchange Commission on August 26 , 2011 Registration Statement No. |
|
| August 26, 2011 |
Greenway Medical Technologies, Inc. 2004 Stock Plan Notice of Stock Option Grant Converted by EDGARwiz Exhibit 10.2.1 Greenway Medical Technologies, Inc. 2004 Stock Plan Notice of Stock Option Grant You have been granted the following option to purchase shares of the Common Stock of Greenway Medical Technologies, Inc. (the “Company”): Name of Optionee: «Name» Total Number of Shares: «TotalShares» Type of Option: «ISO» Incentive Stock Option (ISO) «NSO» Nonstatutory Stock Optio |
|
| August 26, 2011 |
Converted by EDGARwiz Exhibit 10.3.1 ISO AGREEMENT THIS AGREEMENT, entered into as of the Grant Date (as defined in paragraph 1), by and between the Participant and Greenway Medical Technologies Inc. (the “Company”); WITNESSETH THAT: WHEREAS, the Company maintains the 1999 Stock Option Plan (the “Plan”), which is incorporated into and forms a part of this Agreement, and the Participant has been se |
|
| August 26, 2011 |
1(404) 815-2227 [email protected] August 26, 2011 76551.00006 VIA EDGAR AND OVERNIGHT DELIVERY U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549 Attention: Justin Dobbie, Legal Branch Chief Re: Greenway Medical Technologies, Inc. Registration Statement on Form S-1 Filed July 15, 2011 File No. 333-175619 Dear Mr. Dobbie: Enclosed |
|
| August 26, 2011 |
GREENWAY MEDICAL TECHNOLOGIES, INC. 2004 STOCK PLAN ADOPTED ON JUNE 15, 2004 Exhibit 10.2 GREENWAY MEDICAL TECHNOLOGIES, INC. 2004 STOCK PLAN ADOPTED ON JUNE 15, 2004 TABLE OF CONTENTS Page No. SECTION 1. ESTABLISHMENT AND PURPOSE 1 SECTION 2. ADMINISTRATION 1 (a) Committees of the Board of Directors 1 (b) Authority of the Board of Directors 1 SECTION 3. ELIGIBILITY 1 (a) General Rule 1 (b) Ten-Percent Shareholders 1 SECTION 4. STOCK SUBJECT TO PLAN 2 (a) Basic Limitation |
|
| August 26, 2011 |
NON-QUALIFIED STOCK OPTION AGREEMENT Converted by EDGARwiz Exhibit 10.3.2 NON-QUALIFIED STOCK OPTION AGREEMENT THIS OPTION AGREEMENT, made this [], between Greenway Medical Technologies, Inc., a Georgia corporation (the "Corporation"), and [] ("Grantee"); WITNESSETH THAT: WHEREAS, the Corporation maintains the “1999 Stock Option Plan” (the “Plan”), which is incorporated into and forms a part of this Agreement, and the Grantee has bee |
|
| August 26, 2011 |
SECOND AMENDED AND RESTATED VOTING AGREEMENT Converted by EDGARwiz Exhibit 4.3 SECOND AMENDED AND RESTATED VOTING AGREEMENT This SECOND AMENDED AND RESTATED VOTING AGREEMENT (the “Agreement”) is made and entered into effective as of October , 2006, by and among Greenway Medical Technologies, Inc., a Georgia corporation (the “Company”), the holders of the Company’s Series A Preferred Stock (the “Series A Preferred Stock”) listed on Schedule A |
|
| August 26, 2011 |
GREENWAY MEDICAL TECHNOLOGIES 1999 STOCK OPTION PLAN Exhibit 10.3 GREENWAY MEDICAL TECHNOLOGIES 1999 STOCK OPTION PLAN 1. Purpose of the Plan The purpose of this Stock Option Plan is to promote the interests of the Company and its shareholders by providing Employees, Directors and Consultants of the Company and its Affiliates with appropriate incentives and rewards to encourage them to continue in the employ of the Company and maximize their perform |
|
| August 26, 2011 |
Exhibit 10.6 EXECUTION VERSION CREDIT AGREEMENT Dated as of March 22, 2011 among GREENWAY MEDICAL TECHNOLOGIES, INC. as Borrower, BANK OF AMERICA, N.A., as Administrative Agent and LC Issuer, and The Other Lenders Party Hereto TABLE OF CONTENTS Page Article I Definitions and Accounting Terms 1 1.01 Defined Terms 1 1.02 Other Interpretive Provisions 19 1.03 Accounting Terms 20 1.04 Rounding 21 1.05 |
|
| August 12, 2011 |
August 11, 2011 Via E-mail Wyche T. Green, III President, Chief Executive Officer Greenway Medical Technologies, Inc. 121 Greenway Boulevard Carrollton, GA 30117 Re: Greenway Medical Technologies, Inc. Registration Statement on Form S-1 Filed July 15, 2011 File No. 333-175619 Dear Mr. Green: We have reviewed your registration statement and have the following comments. In some of our comments, we m |
|
| July 15, 2011 |
Exhibit 10.6 EXECUTION VERSION CREDIT AGREEMENT Dated as of March 22, 2011 among GREENWAY MEDICAL TECHNOLOGIES, INC. as Borrower, BANK OF AMERICA, N.A., as Administrative Agent and LC Issuer, and The Other Lenders Party Hereto TABLE OF CONTENTS Page Article I Definitions and Accounting Terms 1 1.01 Defined Terms 1 1.02 Other Interpretive Provisions 19 1.03 Accounting Terms 20 1.04 Rounding 21 1.05 |
|
| July 15, 2011 |
Converted by EDGARwiz Exhibit 10.5 TRIPLE NET LEASE ELIZABETH VILLAGE, LLC as Landlord and GREENWAY MEDICAL TECHNOLOGIES, INC. as Tenant 121 Greenway Parkway Carrollton, Georgia Dated as of July 1, 2000 TABLE OF CONTENTS Article Description Page Basic Lease Terms 1 Major Definitions 1 1 Demise of Leased Premises 2 2 Rent 2 3 Use of Leased Premises 3 4 Net Lease 3 5 Signs 4 6 Alterations and Liens |
|
| July 15, 2011 |
As filed with the Securities and Exchange Commission on July 15, 2011 Table of Contents As filed with the Securities and Exchange Commission on July 15, 2011 Registration Statement No. |
|
| July 15, 2011 |
Exhibit 4.2 GREENWAY MEDICAL TECHNOLOGIES, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT OCTOBER 30, 2006 TABLE OF CONTENTS Page 1. Registration Rights 1 1.1 Definitions 1 1.2 Request for Registration 2 1.3 Company Registration 4 1.4 Form S-3 Registration 5 1.5 Obligations of the Company 6 1.6 Information from Holder 7 1.7 Expenses of Registration 7 1.8 Delay of Registration 8 1.9 Indemnif |
|
| July 15, 2011 |
Converted by EDGARwiz Exhibit 10.7 EXECUTION COPY SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”), dated as of March 22, 2011, is by the party identified as “Grantor” on the signature pages hereto and such other parties as may become Grantors hereunder after the date hereof (individually a “Grantor”, and collectively the “Grantors”) and BANK OF AMERICA, N.A., as administrati |
